Reference70 articles.
1. Adamson PC. 1996. All-Trans-Retinoic acid pharmacology and its impact on the treatment of acute promyelocytic leukemia. Oncologist, 1:305–14.
2. Agadir A, Cornic M, Jerome M et al. Chomienne C. 1995a. Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines. Cell specific uptake of ATRA and RAR alpha protein modulation. Biochem Biophys Res Commun, 213:112–22.
3. Agadir A, Cornic M, Lefebvre P, Gourmel B, Balitrand N, Degos L, Chomienne C. 1995b. Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells. evidence for its role in retinoic acid efficacy. Leukemia, 9:139–45.
4. Benedetti L, Grignani F, Scicchitano BM et al. 1996. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase. Blood, 87:1939–50.
5. Boylan JF, Gudas LJ. 1991. Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J Cell Biol, 112:965–79.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献